Ver-Tex Construction company information, Employees & Contact Information

Home Vertex Pharmaceuticals

Vertex’s quest for a breakthrough in Type 1 diabetes Pharma Voice

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd Business Wire

Vertex to Present at Goldman Sachs Communacopia + Technology Conference Yahoo Finance

TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals Time Magazine

Vertex next-generation pain candidate fails Phase 2 trial statnews.com

Vertex’s Islet Cell Therapy Zimislecel (VX-880) Restores Endogenous Insulin Secretion in Type 1 Diabetes CGTLive®

Vertex AI RAG Engine: A developers tool Google for Developers Blog

Vertex discontinues AAV research for gene therapies Fierce Biotech

(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain Vertex Pharmaceuticals Newsroom

FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades CNBC

Vertex Announces Key Advancements Across Kidney Portfolio Business Wire

Tasmea to acquire electrical services company Vertex Mining.com.au

Vertex touts pain drug results, but medicine does not outperform placebo in sciatica study statnews.com

Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo Clinical Trials Arena

a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis Business Wire

Vertex halts development of diabetes cell therapy after trial failure Clinical Trials Arena

Our Science | R&D Pipeline Vertex Pharmaceuticals

Vertex presents data from Phase I/II stage of trial for type 1 diabetes Clinical Trials Arena

Responsibility | Grants and Giving Vertex Pharmaceuticals

Vertex Protocol Team to Join Ink Foundation, Build New DeFi Primitives on Ink Layer-2 Yahoo Finance

Vertex model with internal dissipation enables sustained flows Nature

Responsibility | Our STEAM Commitment Vertex Pharmaceuticals

CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround Fierce Pharma

Our Locations Vertex Pharmaceuticals

Vertex axes Verve gene editing pact amid shift in R&D priorities Fierce Biotech

Non-opioid drug from Vertex cuts pain in major trial tests BioPharma Dive

Editor’s Note: Goodbye, Vertex (Published 2024) The New York Times

Vectrus and Vertex to Combine, Creating a Global Leader in Mission-Essential Solutions PR Newswire

Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership Seeking Alpha

Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis Vertex Pharmaceuticals Newsroom

Vertex, Inc. to Host 2025 Investor Day GlobeNewswire

Vertex cuts ties to CRISPR Therapeutics’ type 1 diabetes stem cell therapy Fierce Biotech

Vertex Cuts Diabetes Asset, but Analysts Keen on Phase III Option BioSpace

Vertex Pharmaceuticals Fierce Pharma

Vectrus and Vertex Complete Combination, Establishing V2X as a Leading Provider of Critical Mission Solutions Globally PR Newswire

Vertex scores FDA nod for long-awaited non-opioid pain reliever Journavx Fierce Pharma

Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout statnews.com

Vertex Experimental Drug Cuts Off Pain at the Source, Company Says The New York Times

Vertex Moon mission getting closer to launch Astronomy Magazine

Vertex posts full pain data ahead of FDA ruling, unpacking combo results, Vicodin miss and stellar safety Fierce Biotech

Lunar Vertex: Solving Mysteries Swirling Around the Moon’s Magnetic Regions Johns Hopkins University Applied Physics Laboratory

Vertex Reports Fourth Quarter and Full Year 2024 Financial Results Business Wire

Vertex Joins Oracle’s Enhanced PartnerNetwork Program GlobeNewswire

Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration Genetic Engineering and Biotechnology News

TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals Time Magazine

CMS enters agreement with Vertex, bluebird to improve access to gene therapies Reuters

Vertex, CRISPR's gene-editing therapy Casgevy wins early FDA nod to treat beta thalassemia Fierce Pharma

Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress Business Wire

This year marks Easson-Vertex’s 22nd anniversary Metalworking News

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline Genetic Engineering and Biotechnology News

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? The Motley Fool

Vertex pauses diabetes cell therapy trial after 2 unrelated patient deaths Fierce Biotech

Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain Business Wire

Vertex drops phase 2 lung therapy, rethinks DMD drug's journey toward clinic Fierce Biotech

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Business Wire

Vertex Pharmaceuticals: Care for Every Life Stage Care.com

Vertex Pharma scientist talks about the long road to developing non-addictive painkillers AP News

Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval Fox Business

Vertex absorbs ViaCyte and its stem cell-based diabetes treatment for $320M, clearing out competition Fierce Biotech

‘A game-changer’: How Vertex delivered on cystic fibrosis statnews.com

Vertex Ventures US Raises $200 Million Third Fund to Double-down on high-conviction approach to venture capital Business Wire

FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment BioSpace

Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy Fierce Biotech

A single patient is producing insulin after treatment with Vertex's new diabetes cell therapy Fierce Biotech

Vertex Pharmaceuticals: Humanizing drug discovery Nature

Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions Business Wire

Structural morphing in a symmetry-mismatched viral vertex Nature

Stablix and Vertex Establish Strategic Collaboration to GlobeNewswire

Vertex Energy unveils new renewable diesel facility in Mobile County AL.com

Better Buy: Vertex vs. CRISPR The Motley Fool

Vertex pays Kymera $70M upfront to discover protein degradation drugs Fierce Biotech

Google introduces Google-Extended to let you block Bard, Vertex AI via robots.txt Search Engine Land

Vertex plunks down $950M for stem cell player Semma Therapeutics Fierce Biotech

Intel buys deep-learning startup Vertex.AI to join its Movidius unit TechCrunch

In-Depth: Vertex, A 'Dirty Dozen' Military Watch Reborn Hodinkee

OCZ Vertex 450 SSD Review StorageReview.com